Responses to parliamentary questions
Question from Deputy John Connolly - PQ 65372-25
Deputy Connolly asked about the inclusion of selpercatinib (also pralsetinib) on the drug reimbursement scheme. Read the HSE response.
From: Communications and public affairs
Published: November 2025
Updated: December 2025
Documents
Question from Deputy John Connolly - PQ 65372-25
PDF, 209KB, 3 pages
Summary
To ask the Minister for Health for an update on the consideration within her Department towards the inclusion of selpercatinib (also pralsetinib) on the drug reimbursement scheme; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it